Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma - No Study Results Posted

Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma (BiovaxID)

This study is ongoing, but not recruiting participants.

Study NCT00091676 Information provided by Biovest International

First Received: September 15, 2004 Last Updated: May 6, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	March 2009
Estimated Primary Completion Date:	March 2009 (Final data collection date for primary outcome measure)